Resumen
BioInnovation Institute (BII) is a life sciences investor and startup facilitator based in Denmark that provides pre-seed and seed-stage equity funding to biotechnology and life science companies. The organization supports early-stage biotech ventures by combining capital investment with infrastructure, expertise, and resources to help transform scientific discoveries into commercial products. BII focuses on advancing innovations in areas such as therapeutics, diagnostics, and industrial biotechnology.